Search

everythinglearnresearchcommunity

for

Search:↓

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Women with epilepsy on certain medications might gain weight and have higher thyroid-stimulating hormone levels, but not more polycystic ovarian syndrome.

Young women with PCOS and no other heart risk factors have normal heart function.

Young Czech women with PCOS have a higher risk of heart problems and should be regularly checked for cholesterol and glucose issues.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Skin problems in patients with polycystic ovarian disease are linked to body weight, blood sugar, and hormone levels.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

Lower hair zinc and copper levels found in Turkish males with hair loss; higher BMI linked to less hair zinc.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Metformin helps improve symptoms and reproductive outcomes in people with polycystic ovary syndrome.

Women with skin conditions who have body image concerns often experience mental health issues and a lower quality of life.

Lifestyle changes and medical treatment can help manage PCOS symptoms in young adults.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Women with PCOS, especially if they are obese, are more likely to have an underactive thyroid than women without PCOS.

Nonobese, normotensive Indian women with PCOS may have a higher risk of heart problems linked to inflammation and insulin resistance.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

Altering SSAT affects fat metabolism and body fat in mice.

Diagnose and manage hair issues in women by checking medical conditions and using personalized treatments.

Adult mice with CBS deficiency show minimal health issues and normal lifespan despite high homocysteine levels.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Shift work disrupts the body's natural clock, leading to health problems.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Fat cells are important for tissue repair and stem cell support in various body parts.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.